Transcriptomic analysis of autistic brain reveals convergent molecular pathology
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index; 19 of the 32 sources its claims cite were checked for support.
Abstract
Autism spectrum disorder (ASD) is a common, highly heritable neurodevelopmental condition characterized by marked genetic heterogeneity. Thus, a fundamental question is whether autism represents an aetiologically heterogeneous disorder in which the myriad genetic or environmental risk factors perturb common underlying molecular pathways in the brain. Here, we demonstrate consistent differences in transcriptome organization between autistic and normal brain by gene co-expression network analysis. Remarkably, regional patterns of gene expression that typically distinguish frontal and temporal cortex are significantly attenuated in the ASD brain, suggesting abnormalities in cortical patterning. We further identify discrete modules of co-expressed genes associated with autism: a neuronal module enriched for known autism susceptibility genes, including the neuronal specific splicing factor A2BP1 (also known as FOX1), and a module enriched for immune genes and glial markers. Using high-throughput RNA sequencing we demonstrate dysregulated splicing of A2BP1-dependent alternative exons in the ASD brain. Moreover, using a published autism genome-wide association study (GWAS) data set, we show that the neuronal module is enriched for genetically associated variants, providing independent support for the causal involvement of these genes in autism. In contrast, the immune-glial module showed no enrichment for autism GWAS signals, indicating a non-genetic aetiology for this process. Collectively, our results provide strong evidence for convergent molecular abnormalities in ASD, and implicate transcriptional and splicing dysregulation as underlying mechanisms of neuronal dysfunction in this disorder.
Overview
CoChat Summary
TL;DR
This study used post-mortem brain transcriptomics and co-expression network analysis to show that autism spectrum disorder (ASD) cortex has convergent molecular abnormalities, including attenuated frontal-temporal regional expression differences and distinct neuronal and immune-glial co-expression modules. It further links a down-regulated neuronal module to autism genetic association signals and demonstrates A2BP1-dependent differential splicing in ASD brain.
Key findings
- In autism cortex, 444 genes were differentially expressed (DE) versus controls, while only 2 genes were DE in cerebellum; the 209 down-regulated genes were enriched for synaptic function and the 235 up-regulated genes for immune/inflammatory response. In an independent BA44/45 replication cohort, 97 genes were DE and 81 overlapped with the initial cohort (p=1.2E-93), with the same direction of change for all but 2 of the 81.
- Regional cortical patterning was attenuated in ASD: 174 genes were DE between control BA9 and BA41 at FDR<1%, but none were DE in the same regional comparison among ASD cases; relaxing to FDR 5% identified over 500 DE genes in controls and only 8 in ASD brains.
- Weighted gene co-expression network analysis identified an under-expressed neuronal module (M12) enriched for known autism susceptibility genes (p=6.1E-4), including CADPS2, AHI1, CNTNAP2, and SLC25A12, and an up-regulated immune-glial module (M16). M12 showed significant enrichment for autism GWAS association signals (p=5E-4), whereas M16 and the DE gene list did not.
- RNA-Seq on 3 ASD samples with low A2BP1 and 3 controls identified 212 significant alternative splicing events; 36 overlapped with predicted A2BP1/2 targets (p=2.2E-16), and RT-PCR confirmed 85% of tested differential splicing changes involving predicted A2BP1 targets.
Methods
- Post-mortem brain tissue was obtained from the Autism Tissue Project, Harvard Brain Bank, and MRC London Brain Bank. Illumina microarrays profiled superior temporal gyrus (BA41/42), prefrontal cortex (BA9), and cerebellar vermis; after filtering, 58 cortex samples (29 ASD, 29 controls) and 21 cerebellum samples (11 ASD, 10 controls) were analyzed, with an independent BA44/45 replication cohort of 9 ASD cases and 5 controls.
- Analyses included differential expression, supervised hierarchical clustering, weighted gene co-expression network analysis (WGCNA), gene ontology enrichment, and GWAS set enrichment using a published autism GWAS dataset plus negative-control GWAS datasets.
- High-throughput RNA-Seq was performed on 3 ASD samples with significant A2BP1 down-regulation (average fold change by qRT-PCR: 5.9) and 3 control samples with average A2BP1 levels, followed by RT-PCR validation.
Limitations
- The paper does not include a dedicated limitations section.
- The text makes evident that the RNA-Seq comparison used a very small sample (3 ASD, 3 controls) and the replication cohort was also small (9 ASD, 5 controls).
- The study relies on post-mortem brain tissue; potential confounders such as age, sex, RNA integrity number, post-mortem interval, seizure co-morbidity, and medication were assessed, but the authors state that immune changes have no evidence of a common genetic component and are most likely secondary or environmental.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
16 Valid · 0 Not valid · 8 Not checked · 93 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“The hubs of M12, i.e. the genes with the highest rank of M12 membership 8 , were A2BP1, APBA2, SCAMP5, CNTNAP1, KLC2, CHRM1 (Supplementary Data).”
What the sources say
- Supportedcites [8] 8. Oldham MC, Konopka G, Iwamoto K, Langfelder P, Kato T, Horvath S, Geschwind DH. Functional organization of the transcriptome in human brain. Nat Neurosci. 2008; 11:1271-1282. [PubMed: 18849986] source
The citation is attached to the definition of module membership used to identify hubs, not to the six-gene list, which the citing sentence attributes to its Supplementary Data. The Results section (“Module membership is highly consistent”; page unavailable) defines module membership, and the Methods section (“Defining a measure of module membership (kME)”; page unavailable) explains how genes are ranked by it. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The control brain network showed high similarity with the previously described human brain co-expression networks (Supplementary Table 7), consistent with the existence of robust modules of co-expressed genes related to specific cell types and biological functions 8 .”
What the sources say
- Supportedcites [8] 8. Oldham MC, Konopka G, Iwamoto K, Langfelder P, Kato T, Horvath S, Geschwind DH. Functional organization of the transcriptome in human brain. Nat Neurosci. 2008; 11:1271-1282. [PubMed: 18849986] source
The citation supports the sentence’s final clause: the Results sections ‘Conserved modules are enriched for markers of cell classes’ and ‘Relationships between modules are highly preserved’ describe reproducible co-expression modules associated with cell types and biological functions. The similarity of the citing authors’ control network to earlier networks is their own comparison, reported in their Supplementary Table 7, rather than a finding attributed to this source. Page numbers were not available in our copy. (LLM, conf=0.91)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“M12 showed significant overrepresentation of known autism susceptibility genes 2 (Supplementary Table 10; p = 6.1E-4), including CADPS2 , AHI1 , CNTNAP2 , and SLC25A12”
What the sources say
- Partly supportedcites [2] 2. Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, Regan R, Conroy J, Magalhaes TR, Correia C, Abrahams BS, et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature. 2010; 466:368-372. [PubMed: 20531469] sourceExperimental — accuracy not yet measured
The main text (Figure 2 and the accompanying results; page not provided) discusses a set of ASD-implicated genes, supporting the general description attached to citation 2. Our copy does not identify CADPS2, AHI1, CNTNAP2, or SLC25A12 as members of that set, so it cannot verify the specific examples. The M12 enrichment and p value are presented as the citing paper’s own analysis, not as findings of this source. (LLM, conf=0.77)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“The first three of these genes have previously been implicated in autism 14-16”
What the sources say
- Not checked — no full text of the sourcecites [14] 14. Babatz TD, Kumar RA, Sudi J, Dobyns WB, Christian SL. Copy number and sequence variants implicate APBA2 as an autism candidate gene. Autism Res. 2009; 2:359-364. [PubMed: 20029827] source
- Supportedcites [15] 15. Castermans D, Volders K, Crepel A, Backx L, De Vos R, Freson K, Meulemans S, Vermeesch JR, Schrander-Stumpel CT, De Rijk P, et al. SCAMP5, NBEA and AMISYN: three candidate genes for autism involved in secretion of large dense-core vesicles. Hum Mol Genet. 2010; 19:13681378. [PubMed: 20071347] source
The Abstract identifies SCAMP5 as a candidate gene for autism and reports its disruption in a patient with autism. In the citing sentence’s group of three references, this paper supports the SCAMP5 portion of the claim. (LLM, conf=0.92)
- Not checked — no full text of the sourcecites [16] 16. Martin CL, Duvall JA, Ilkin Y, Simon JS, Arreaza MG, Wilkes K, Alvarez-Retuerto A, Whichello A, Powell CM, Rao K, et al. Cytogenetic and molecular characterization of A2BP1/FOX1 as a candidate gene for autism. Am J Med Genet B Neuropsychiatr Genet. 2007; 144B:869-876. [PubMed: 17503474] source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“showed significant similarity to two modules identified in previous studies of normal human brain 8 : an astrocyte module and a microglial module.”
What the sources say
- Supportedcites [8] 8. Oldham MC, Konopka G, Iwamoto K, Langfelder P, Kato T, Horvath S, Geschwind DH. Functional organization of the transcriptome in human brain. Nat Neurosci. 2008; 11:1271-1282. [PubMed: 18849986] source
The Results section identifies a module of coexpressed genes with characteristics of microglia in human brain. The citation identifies the earlier microglial module; the statement that the citing study’s M16 was significantly similar to it is the citing authors’ comparison, not a finding attributed to Oldham et al. No page number is available in our copy. (LLM, conf=0.88)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
95 more claims · 6 with their cited sources checked
Create a free account to see all 117 claims and every source verdict.
- It may state two separate claims as one. 14
- Probably not a substantial claim. 5
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Although there was no significant DGE in the cerebellum (FDR < 0.05, P distributions in Fig. 1b), similar to observations in a smaller cohort8, there was a replication signal in the cerebellum and overall concordance between ASD-related fold changes in the cortex and cerebellum (Extended Data Fig. 2f–h).”
From Genome-wide changes in lncRNA, splicing, and regional gene expression patterns in autism (2016) · cites this paper as [8]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These results are consistent with previous studies in post-mortem brain that identified dysregulation of gene expression in microglia but enriched expression of ASD risk genes only in neuronal cells (Ruzzo et al., 2019; Gandal et al., 2018a, 2018b; Voineagu et al., 2011).”
From Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism (2020) · cites this paper as Voineagu et al., 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Gene expression changes in postmortem brain overlap with developmentally regulated genes involved in cortical patterning as well as in cell cycle, proliferation and neural differentiation6, 7.”
From Altered proliferation and networks in neural cells derived from idiopathic autistic individuals (2017) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Upregulation of immune genes and downregulation of synaptic genes was observed in postmortem brain from idiopathic ASD (Voineagu et al., 2011), and this finding has been replicated in a larger ASD sample (Gupta et al., 2014).”
From Getting to the cores of autism (2019) · cites this paper as Voineagu et al., 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This hypothesis was supported both by the significant overlap between candidate autism-susceptibility genes and Rbfox target genes and by the significant overlap of predicted Rbfox target exons and exons altered in autistic brains with down-regulation of Rbfox1 (Voineagu et al., 2011).”
From HITS-CLIP and integrative modeling define the Rbfox splicing-regulatory network linked to brain development and autism (2014) · cites this paper as Voineagu et al., 2011
Experimental — accuracy not yet measured
81 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
WGCNA: an R package for weighted correlation network analysis
Langfelder, P., & Horvath, S. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-559 · Cited by 27,252
Self-citationA General Framework for Weighted Gene Co-Expression Network Analysis
Zhang, B., & Horvath, S. (2005) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1128 · Cited by 5,684 · cited 5×
“We next applied weighted-gene co-expression network analysis (WGCNA) 8; 9 to integrate the expression differences observed between autistic and control cerebral cortex into a higher order, systems level context.”
InfluentialSelf-citationPan, Q., Shai, O., Lee, L. J., Frey, B. J., & Blencowe, B. J. (2008) · Nature Genetics · doi:10.1038/ng.259 · Cited by 3,951
Self-citationCahoy, J. D., Emery, B., Kaushal, A., Foo, L. C., Zamanian, J. L., Christopherson, K. S., Xing, Y., Lubischer, J. L., Krieg, P. A., Krupenko, S. A., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4178-07.2008 · Cited by 3,129
Strong association of de novo copy number mutations with autism
Sebat, J., Lakshmi, B., Malhotra, D., Troge, J., Lese-Martin, C., Walsh, T., Yamrom, B., Yoon, S., Krasnitz, A., Kendall, J., et al. (2007) · Science · doi:10.1126/science.1138659 · Cited by 2,795
Self-citationFunctional impact of global rare copy number variation in autism spectrum disorders
Pinto, D., Pagnamenta, A. T., Klei, L., Anney, R., Merico, D., Regan, R., Conroy, J., Magalhaes, T. R., Correia, C., Abrahams, B. S., et al. (2010) · Nature · doi:10.1038/nature09146 · Cited by 2,013 · cited 1×
“These results indicate that (1) M12 consists of a set of genes that are supported by independent lines of evidence to be causally involved in ASD pathophysiology, and (2) the upregulation of immune response genes in the autistic brain observed by us and others(25) has no evidence of a common genetic component.”
Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R
Langfelder, P., Zhang, B., & Horvath, S. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btm563 · Cited by 1,892
Self-citationAdvances in autism genetics: on the threshold of a new neurobiology
Abrahams, B. S., & Geschwind, D. H. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2346 · Cited by 1,866 · cited 3×
“%) showed significant overlap with the previously described human brain modules (Supplementary Table 6), indicating that many features reflecting the general organization of the autism brain transcriptome are consistent with that of the normal human brain.”
InfluentialSelf-citationDurand, C. M., Betancur, C., Boeckers, T. M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I. C., Anckarsäter, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1933 · Cited by 1,602
Amaral, D. G., Schumann, C. M., & Nordahl, C. W. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2007.12.005 · Cited by 1,492 · cited 1×
“In addition, comparison of these DE results with another, smaller study of the STG in ASD 7 , revealed significant consistency at the level of DE genes, including down-regulation of DLX1 and AHI1 (Supplementary Table 5).”
Research works printed but not linked: 1
- 8. Oldham MC, Konopka G, Iwamoto K, Langfelder P, Kato T, Horvath S, Geschwind DH. Functional organization of the transcriptome in human brain. Nat Neurosci. 2008; 11:1271-1282. [PubMed: 18849986] · DOI · Paper page
Cited by
Items 801–900 of 1,888
van Eyk, C. L., Corbett, M. A., Gardner, A. E., van Bon, B. W. M., Broadbent, J. L., Harper, K., MacLennan, A. H., & Gécz, J. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0136-4 · Cited by 36
Autism throughout genetics: Perusal of the implication of ion channels
Daghsni, M., Rima, M., Fajloun, Z., Ronjat, M., Brusés, J. L., Mrad, R., & WAARD, M. M. D. (2018) · Brain and Behavior · doi:10.1002/brb3.978 · Cited by 37
Stacey, D., Schubert, K. O., Clark, S. R., Amare, A. T., Milanesi, E., Maj, C., Leckband, S. G., Shekhtman, T., Kelsoe, J. R., Gurwitz, D., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0237-0 · Cited by 32
Sgadó, P., Provenzano, G., Dassi, E., Adami, V., Zunino, G., Genovesi, S., Casarosa, S., & Bozzi, Y. (2013) · Molecular Autism · doi:10.1186/2040-2392-4-51 · Cited by 37
“Moreover, the transcriptome profiles from three different brain regions (frontal cortex, temporal cortex and cerebellum) of nineteen autism cases and seventeen controls were investigated recently using classical differential expression analysis and a network-based approach [9].”
BackgroundMethodResultInfluentialAltered expression of mRNA profiles in blood of early-onset schizophrenia
Xu, Y. J., Shugart, Y. Y., Wang, G., Cheng, Z., Jin, C., Zhang, K., Wang, J., Yu, H., Yue, W., Zhang, F., et al. (2016) · Scientific Reports · doi:10.1038/srep16767 · Cited by 30
A common molecular signature in ASD gene expression: following Root 66 to autism
Díaz-Beltrán, L., Esteban, F. J., & Wall, D. P. (2016) · Translational Psychiatry · doi:10.1038/tp.2015.112 · Cited by 30
Strand-specific RNA-sequencing analysis of multiple system atrophy brain transcriptome
Mills, J. D., Ward, M., Kim, W. S., Halliday, G. M., & Janitz, M. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.02.042 · Cited by 32
“…al., 2013; Li et al., 2014), as well as to profile the brain in healthy people without neurological or psychiatric conditions (Mazin et al., 2013; Mills et al., 2013a; Smith et al., 2013) and those with Alzheimer’s disease (Twine et al., 2011; Mills et al., 2013c) or autism (Voineagu et al., 2011).”
Neuroinflammation in Autism Spectrum Disorders: Role of High Mobility Group Box 1 Protein.
Dipasquale, V., Cutrupi, M. C., Colavita, L., Manti, S., Cuppari, C., & Salpietro, C. D. (2017) · PubMed Central · doi:10.22088/acadpub.bums.6.3.148 · Cited by 37
Schulz, D., Morschel, J., Schuster, S., Eulenburg, V., & Gomeza, J. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00279 · Cited by 33
“, 2015) and transcriptomic analyses have revealed a decreased expression of PROT in post-mortem autistic brains (Voineagu et al., 2011).”
BackgroundShi, J., Zhang, P., Liu, L., Min, X., & Xiao, Y. (2019) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.982 · Cited by 30
“The WGCNA algorithm has been proven in applications ranging from oncology (Chen et al., 2018), neurology (Voineagu et al., 2011) etc.”
MethodNakajima, M., Schmitt, L. I., Feng, G., & Halassa, M. M. (2019) · Neuron · doi:10.1016/j.neuron.2019.09.040 · Cited by 34
Filosi, M., Kam‐Thong, T., Essioux, L., Muglia, P., Trabetti, E., Spooren, W. P. J. M., Müller-Myshok, B., Italian Autism Network, Allibrio, G., Anchisi, L., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0778-x · Cited by 37
The role of neuroglia in autism spectrum disorders
Scuderi, C., & Verkhratsky, A. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.04.011 · Cited by 31
Brain mRNA Expression Associated with Cortical Volume Alterations in Autism Spectrum Disorder
Xie, Y., Zhang, X., Liu, F., Qin, W., Fu, J., Xue, K., & Yu, C. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108137 · Cited by 32
Elucidating the cellular dynamics of the brain with single-cell RNA sequencing
Cardona‐Alberich, A., Tourbez, M., Pearce, S. F., & Sibley, C. R. (2021) · RNA Biology · doi:10.1080/15476286.2020.1870362 · Cited by 34
“Whilst much progress has recently been made characterizing the convergent transcriptomic mechanisms and signatures which are characteristic of ASDs at the bulk RNA-seq level [80,81], these”
BackgroundAfridi, R., Seol, S., Kang, H. J., & Suk, K. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114532 · Cited by 31
Chaudhary, R., Morris, R. J., & Steinson, E. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577633 · Cited by 33
Toriumi, K., Berto, S., Koike, S., Usui, N., Dan, T., Suzuki, K., Miyashita, M., Horiuchi, Y., Yoshikawa, A., Asakura, M., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102057 · Cited by 38
“The 286 DEGs were also enriched with genes in an asdM16 module, which is related to autism spectrum disorder (ASD), and enriched for genes involved in immune and inflammatory responses [30], but was not enriched for schizophrenia related genes (Fig.”
BackgroundMethodUsui, N., Ono, Y., Aramaki, R., Berto, S., Konopka, G., Matsuzaki, H., & Shimada, S. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.754198 · Cited by 31
“The list of autism spectrum disorder (ASD) genes was derived from the SFARI database (1010 genes; https://gene.sfari.org/database/ human-gene).”
BackgroundInfluentialZhang, W., Ross, P. J., Ellis, J., & Salter, M. W. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02010-z · Cited by 38
Stoccoro, A., Conti, E., Scaffei, E., Calderoni, S., Coppedè, F., Migliore, L., & Battini, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119138 · Cited by 40
“Interestingly, OR2L13 has also been found to be differentially expressed in the brain samples of ASD patients [57], further suggesting its potential usefulness as an ASD peripheral biomarker and a target for understanding ASD etiology.”
BackgroundChan, S. F., Huang, X., McKercher, S. R., Zaidi, R., Okamoto, S., Nakanishi, N., & Lipton, S. A. (2014) · Genomics Data · doi:10.1016/j.gdata.2014.10.022 · Cited by 35
“Additionally, transcriptome analyses of human ASD brains have identified MEF2C as a “node” connecting various genes affected in autism [9,10].”
BackgroundTranscriptomic Approaches to Neural Repair
Dulin, J. N., Antunes‐Martins, A., Chandran, V., Costigan, M., Lerch, J. K., Willis, D. E., & Tuszynski, M. H. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2599-15.2015 · Cited by 34
“…the transcriptional state of a tissue or cell population, yielding information about alternative splicing and novel isoforms (Roberts et al., 2011; Voineagu et al., 2011), diverse classes of noncoding RNA (Shao et al., 2010; Belgard et al., 2011), and post-transcriptional RNA editing (Danecek et…”
BackgroundFunctional Genomic Analyses Identify Pathways Dysregulated in Animal Model of Autism
Huang, J., Tian, Y., Wang, H., Shen, H., Wang, H., Long, S., Liao, M., Liu, Z., Wang, Z., Li, D., et al. (2016) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12582 · Cited by 33
“profiles are highly correlated across samples and give rise to several gene modules containing subsets of genes with similar biochemical and functional properties as well as anatomical localization [7,9,11].”
BackgroundSelf-citationHui, K. K., Katayama, Y., Nakayama, K. I., Nomura, J., & Sakurai, T. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.08.001 · Cited by 31
Lombardo, M. V. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0773-x · Cited by 40
“However, in our recent paper [4] we re-analyzed data from these studies [2, 3] and indeed identified 2 consensus co-expression modules enriched in translation processes (M1 and M25) that were replicably upregulated in autism in both datasets.”
BackgroundGolden, C. E. M., Breen, M. S., Koro, L., Sonar, S., Niblo, K., Browne, A., Burlant, N., Di Marino, D., De Rubeis, S., Baxter, M. G., et al. (2019) · Cerebral Cortex · doi:10.1093/cercor/bhz029 · Cited by 29
“For this purpose, we created separate transcriptional networks from previously published human cortex tissue (BA 9/41) sampled from control individuals (Voineagu et al. 2011) in order to systematically explore potential species similarities and differences.”
BackgroundMethodInhibiting proBDNF to mature BDNF conversion leads to ASD-like phenotypes in vivo
Yang, F., You, H., Mizui, T., Ishikawa, Y., Takao, K., Miyakawa, T., Li, X., Bai, T., Xia, K., Zhang, L., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02595-5 · Cited by 42
“Therefore, we examined the RNA-seq data sourced from ASD postmortem brains in the human BrainEXP-NPD database (http://www.brainexpnpd.org/boxresult.html?value = BDNF = ASD) [66, 67].”
Gao, Y., Shonai, D., Trn, M., Zhao, J., Soderblom, E. J., Garcia-Moreno, S. A., Gersbach, C. A., Wetsel, W. C., Dawson, G., Velmeshev, D., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51037-x · Cited by 38
Mitochondria and the non‐genetic origins of cell‐to‐cell variability: More is different
Guantes, R., Díaz‐Colunga, J., & Iborra, F. J. (2015) · BioEssays · doi:10.1002/bies.201500082 · Cited by 35
“In neurodegenerative diseases, such as Alzheimer and Parkinson, and neurodevelopmental diseases like autism, aberrant AS has been documented [115].”
BackgroundSpreafico, R., Rossetti, M. M., Whitaker, J. W., Wang, W., Lovell, D. J., & Albani, S. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1524056113 · Cited by 30
Genomic updates in understanding PTSD
Sharma, S. K., & Ressler, K. J. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.11.010 · Cited by 30
Reciprocal control of translation and transcription in autism spectrum disorder
Longo, F., & Klann, E. (2021) · EMBO Reports · doi:10.15252/embr.202052110 · Cited by 30
“Examination of the different genetic studies and transcriptomic analyses (Voineagu et al, 2011; De Rubeis et al, 2014; Gupta et al, 2014) that have been performed to date indicates that ASD-associated genes are often regulators of the expression of a large group of other genes with multiple…”
Quantifying transcriptome diversity: a review
Jones, E. F., Haldar, A., Oza, V. H., & Lasseigne, B. N. (2023) · Briefings in Functional Genomics · doi:10.1093/bfgp/elad019 · Cited by 35
An Ultrasensitive Mechanism Regulates Influenza Virus-Induced Inflammation
Shoemaker, J. E., Fukuyama, S., Eisfeld, A. J., Zhao, D., Kawakami, E., Sakabe, S., Maemura, T., Gorai, T., Katsura, H., Muramoto, Y., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004856 · Cited by 37
“A further advantage of a network approach is that the functional relevance of genes might be inferred from their positions within the co-expression network [28].”
BackgroundHeck, A., Fastenrath, M., Coynel, D., Auschra, B., Bickel, H., Freytag, V., Gschwind, L., Hartmann, F., Jessen, F., Kaduszkiewicz, H., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.1309 · Cited by 29
Anderson, G., & Maes, M. H. J. (2014) · Current Neuropharmacology · doi:10.2174/1570159x11666131120223757 · Cited by 33
“In a comparison of gene transcription differences in ASD brains versus controls, two main categories emerged: the first showing suppressed transcription at the synapse; the second showing increased glia and immune activation [239].”
BackgroundHuman Genomic Signatures of Brain Oscillations During Memory Encoding
Berto, S., Wang, G.-Z., Germi, J., Lega, B. C., & Konopka, G. (2017) · Cerebral Cortex · doi:10.1093/cercor/bhx083 · Cited by 29
Neurodevelopmental disorder-associated ZBTB20 gene variants affect dendritic and synaptic structure
Jones, K. A., Luo, Y. Y., Dukes‐Rimsky, L., Srivastava, D. P., Koul‐Tiwari, R., Russell, T. A., Shapiro, L. P., Srivastava, A. K., & Penzes, P. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203760 · Cited by 31
Chromatin regulators, phenotypic robustness, and autism risk
Suliman, R., Ben-David, E., & Shifman, S. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00081 · Cited by 28
“In addition, rare and de novo large chromosomal rearrangements are also found more frequently in ASD, currently estimated to account for 2–7% of cases (Marshall et al., 2008; Shen et al., 2010).”
BackgroundNahas, L. D., Datta, A., Alsamman, A. M., Adly, M. H., Al-Dewik, N. I. E., Sekaran, K., Sasikumar, K., Verma, K., Doss, C. G. P., & Zayed, H. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01322-3 · Cited by 44
“This method has been used to study the pathology of ASD and to detect differentially expressed genes (DEGs) among individuals who are autistic and normal (Kuwano et al. 2011; Sekaran et al. 2021; Voineagu et al. 2011; Hu and Lai 2013; Sarachana and Hu 2013).”
MethodMaternal Immune Activation and Autism in Offspring: What Is the Evidence for Causation?
Gardner, R. M., Brynge, M., Sjöqvist, H., Dalman, C., & Karlsson, H. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.11.009 · Cited by 43
Working up autism: The practical role of medical genetics
Gurrieri, F. (2012) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31326 · Cited by 33
“[Voineagu et al., 2011] will increase our understanding of the genetic causes of ASD.”
BackgroundThe autism puzzle: challenging a mechanistic model on conceptual and historical grounds
Verhoeff, B. (2013) · Philosophy Ethics and Humanities in Medicine · doi:10.1186/1747-5341-8-17 · Cited by 33
“[29] provide evidence for convergent molecular abnormalities in ASD, and implicate ‘transcriptional and splicing dysregulation as underlying mechanisms of neuronal dysfunction in this disorder’ (p.”
BackgroundMeta-analysis of differentially expressed genes in autism based on gene expression data
Ning, L., Yu, Y., GuoJi, E. T., Kou, C., Wu, Y., Shi, J., Ai, L., & Yu, Q. (2015) · Genetics and Molecular Research · doi:10.4238/2015.march.27.1 · Cited by 30
“The characteristics of studies included in this analysis are listed in Table 1 (Nishimura et al., 2007; Gregg et al., 2008; Hu et al., 2009a,b; Alter et al., 2011; Voineagu et al., 2011; Kuwano et al., 2011; Ginsberg et al., 2012).”
BackgroundKrausová, B. H., Slavíková, B., Nekardová, M., Hubálková, P., Vyklický, V., Chodounská, H., Vyklický, L., & Kudová, E. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00255 · Cited by 29
webCEMiTool: Co-expression Modular Analysis Made Easy
Cardozo, L. E., Russo, P. S. T., Gomes-Correia, B., Araújo‐Pereira, M., Sepúlveda-Hermosilla, G., Maracaja‐Coutinho, V., & Nakaya, H. I. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00146 · Cited by 30
“Such analysis was applied to reveal functional modules related to infectious (Janova et al., 2015), inflammatory (Beins et al., 2016), and neurological (Voineagu et al., 2011) diseases, as well as several types of cancer (Sharma et al., 2017).”
BackgroundThe effect of tissue composition on gene co-expression
Zhang, Y., Cuerdo, J., Halushka, M. K., & McCall, M. N. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbz135 · Cited by 29
“Gene co-expression networks encode similarities in expression as edges in an undirected graph and have been used to identify genes that potentially share a regulatory relationship or common function [4, 6, 34, 36].”
Elucidation of Biological Networks across Complex Diseases Using Single-Cell Omics
Li, Y., Ma, A., Mathé, E. A., Li, L., Liu, B., & Ma, Q. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.08.004 · Cited by 26
“Specifically, a co-expression network ( GCN ) is a comprehensive compilation of co-expression linkages among genes, which can be inferred from single-cell RNA-Sequencing (scRNA-Seq) [36– 41].”
BackgroundInfluentialJęśko, H. M., Cieślik, M., Gromadzka, G., & Adamczyk, A. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104853 · Cited by 30
Biological implications of genetic variations in autism spectrum disorders from genomics studies
Zhang, Y., Liu, X., Guo, R., Xu, W., Guo, Q., Hao, C., Ni, X., & Li, W. (2021) · Bioscience Reports · doi:10.1042/bsr20210593 · Cited by 35
Pescosolido, M. F., Yang, U., Sabbagh, M. F., & Morrow, E. M. (2012) · Dialogues in Clinical Neuroscience · doi:10.1080/19585969.2022.12130883 · Cited by 34
“The aforementioned transcriptome analysis not only revealed A2BP1 to be downregulated in comparison to control tissue but also determined many of the protein’s targets were genes involved in synaptic function.(34) In line with the CNV data, this suggests that the disorder may come about not from the perturbation of a…”
BackgroundResultAnnamneedi, A., Gora, C., Dudas, A., Leray, X., Bozon, V., Crépieux, P., & Pellissier, L. P. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16216 · Cited by 33
“Furthermore, two studies have found downregulated GPR85 transcripts and decreased GPR85 splicing events in the cortex of ASD patients (Voineagu et al., 2011; Monfared et al., 2021).”
BackgroundLangfelder, P., Castellani, L. W., Zhou, Z., Paul, E., Davis, R. C., Schadt, E. E., Lusis, A. J., Horvath, S., & Mehrabian, M. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.07.014 · Cited by 33
Self-citationUrraca, N., Hope, K. A., Victor, A. K., Belgard, T. G., Memon, R., Goorha, S., Valdez, C., Tran, Q. T., Sánchez, S., Ramírez, J., et al. (2018) · Molecular Autism · doi:10.1186/s13229-018-0191-y · Cited by 32
“As Dup15q syndrome is a common cause of ASD, which is known to have a convergent molecular pathology [46], we compared our gene expression results with postmortem gene expression data in a recently published RNAseq study of both Dup15q and idiopathic ASD cases compared to control brain [39] (Fig.”
ResultA Cell Type-Specific Expression Signature Predicts Haploinsufficient Autism-Susceptibility Genes
Zhang, C., & Shen, Y. (2016) · Human Mutation · doi:10.1002/humu.23147 · Cited by 28
“…2011], and that candidate autism-associated genes show significant overlap with target transcripts of several neuronal RNAbinding proteins including FMRP [Darnell et al., 2011; Iossifov et al., 2012] and RBFOX1 (A2BP1) [Voineagu et al., 2011; WeynVanhentenryck et al., 2014; Zhang et al., 2010].”
BackgroundMethodFunctional genomics of human brain development and implications for autism spectrum disorders
Ziats, M. N., Grosvenor, L. P., & Rennert, O. M. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.153 · Cited by 32
Zhang, S., Yang, W., Zhao, Q., Zhou, X., Jiang, L., Ma, S., Liu, X., Li, Y., Zhang, C., Fan, Y., et al. (2016) · BMC Genomics · doi:10.1186/s12864-016-2476-x · Cited by 29
“Modules [33, 36], which contain information regarding which biological processes are related to the candidate genes or metabolites, can be extracted from a co-expression network.”
BackgroundKim, U.-J., Hong, N., & Ahn, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416099 · Cited by 32
“In a previous study, RNA sequencing revealed a close association between genes involved in ASD and glial cell activation, and genes involved in immune and inflammatory responses [28].”
BackgroundSamuels, B. A., Leonardo, E. D., Dranovsky, A., Williams, A., Wong, E. H. F., Nesbitt, A. M. I., McCurdy, R. D., Hen, R., & Alter, M. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085136 · Cited by 29
“expression systems[4,22,23,24,25].”
Lotan, A., Lifschytz, T., Slonimsky, A., Broner, E. C., Greenbaum, L., Abedat, S., Fellig, Y., Cohen, H. R., Lory, O., Goelman, G., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.123 · Cited by 32
Key regulators in prostate cancer identified by co-expression module analysis
Jiang, J., Jia, P., Zhao, Z., & Shen, B. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-1015 · Cited by 28
“We excluded the samples with low mean IAC and/or those that emerged as a clear outlier by the hierarchical clustering approach [34].”
MethodGenomics in Neurological Disorders
Han, G., Sun, J., Wang, J., Bai, Z., Song, F., & Lei, H. (2014) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2014.07.002 · Cited by 32
“In a study by Geschwind and coworkers, the dysregulation of gene expression in the autistic brains was investigated [14].”
BackgroundAltered brain network dynamics in youths with autism spectrum disorder
Malaia, E., Bates, E., Seitzman, B. A., & Coppess, K. R. (2016) · Experimental Brain Research · doi:10.1007/s00221-016-4737-y · Cited by 32
“…disorders characterized by behavioral impairments in social interaction, communication, and behavioral flexibility, as well as pathophysiological connectivity abnormalities in brain networks (Sun et al. 2012; Voineagu et al. 2011; Geschwind and Levitt 2007; Uhlhaas and Singer 2006).”
Nicole, O., Bell, D. M., Lesté-Lasserre, T., Doat, H., Guillemot, F., & Pacary, E. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0046-0 · Cited by 30
“expression is associated with multiple psychiatric illnesses [25, 63, 64], the identification of the upstream regulation of CaMKIIβ expression would provide a clue as to the original signal potentially leading to brain dysfunction.”
Vardarajan, B. N., Eran, A., Jung, J.-Y., Kunkel, L. M., & Wall, D. P. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.38 · Cited by 26
Rastogi, M., Bartolucci, M., Nanni, M., Aloisio, M., Vozzi, D., Petretto, A., Contestabile, A., & Cancedda, L. (2024) · Neuron · doi:10.1016/j.neuron.2024.05.002 · Cited by 26
Exploiting aberrant mRNA expression in autism for gene discovery and diagnosis
Guan, J., Yang, E., Yang, J., Zeng, Y., Ji, G., & Cai, J. J. (2016) · Human Genetics · doi:10.1007/s00439-016-1673-7 · Cited by 30
“Autism spectrum disorder (ASD, [OMIM 209850]) is a complex neurodevelopmental condition characterized by substantial phenotypic and genetic heterogeneity (Devlin and Scherer 2012; Geschwind 2011; Geschwind and State 2015; Willsey and State 2015).”
BackgroundLi, Y., Kim, R., Cho, Y. S., Song, W. S., Kim, D., Kim, K., Roh, J. D., Chung, C., Park, H., Yang, E., et al. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.3321-17.2018 · Cited by 25
“SALM1/LRFN2 has been associated with autism spectrum disorders (ASDs) (Voineagu et al., 2011; Morimura et al., 2017), schizophrenia (Morimura et al., 2017), working memory deficits (Thevenon et al., 2016), and antisocial personality disorders (Rautiainen et al., 2016).”
BackgroundProtein Biomarkers of Autism Spectrum Disorder Identified by Computational and Experimental Methods
Yao, F., Zhang, K., Feng, C., Gao, Y. L., Shen, L., Liu, X., & Ni, J. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.554621 · Cited by 30
“One dataset, GSE28521 (24), was selected for data analysis according to the following criteria.”
BackgroundMethodTraetta, M. E., Uccelli, N. A., Zárate, S., Cuautle, D. G., Ramos, A. J., & Reinés, A. G. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.707859 · Cited by 33
Defining the nature of human pluripotent stem cell-derived interneurons via single-cell analysis
Allison, T. F., Langerman, J., Sabri, S., Otero‐García, M., Lund, A. J., Huang, J. C., Wei, X., Samarasinghe, R. A., Polioudakis, D., Módy, I., et al. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.08.006 · Cited by 24
“The most primitive developmental stage (Dev1, cluster 6) showed a strong enrichment for the splicing and regulation of mRNA, which has been previously described as an enriched feature of developing tissues, including the CNS (Figure 2E) (Lopez, 1998; Voineagu et al., 2011; Wamsley et al., 2018).”
BackgroundSelf-citationReis, V. N. D. S., Tahira, A. C., Gastaldi, V. D., Mari, P., Portolese, J., dos Santos, A. C. F., Lisbôa, B. C. G., Mari, J. D. J., Caetano, S. C., Brunoni, D., et al. (2021) · Genes · doi:10.3390/genes12091433 · Cited by 33
“So, even individuals in group B having more familial history than in group A, which implies a larger polygenic genetic background [38,81], the subgroups were not represented by extremes of genetic background and environmental exposure as previously suggested [82].”
ResultLactobacillus reuteri normalizes altered fear memory in male Cntnap4 knockout mice
Zhang, W., Huang, J., Gao, F., You, Q.-L., Ding, L., Gong, J., Zhang, M., Ma, R., Zheng, S., Sun, X., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104323 · Cited by 31
Guerra, M., Medici, V., Weatheritt, R. J., Corvino, V., Palacios, D., Geloso, M. C., Farini, D., & Sette, C. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02391-9 · Cited by 30
“In further support of a specific link between gene expression modulation during post-natal cerebellar development and ASD, analysis of genes differentially expressed Translational Psychiatry (2023) 13:114 in two studies of post-mortem ASD brains (GSE28521, GSE64018) [19, 37] indicated a significant overlap (Fig.”
BackgroundMethodResultInfluentialAstrocytes and microglia in the coordination of CNS development and homeostasis
Lopez‐Ortiz, A. O., & Eyo, U. B. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.16006 · Cited by 51
“…of post-mortem samples revealed a close association of glial cell activation in ASD: Individuals with autism exhibited up-regulation of specific astrocytes and microglial genes (Edmonson et al., 2014), as well as in genes involved in immune and inflammatory pathways (Voineagu et al., 2011).”
Simon, J. M., Paranjape, S. R., Wolter, J. M., Salazar, G., & Zylka, M. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-39016-5 · Cited by 24
Autism and EMF? Plausibility of a pathophysiological link part II
Herbert, M. R., & Sage, C. (2013) · Pathophysiology · doi:10.1016/j.pathophys.2013.08.002 · Cited by 30
“Voineaugu and colleagues perormed transcriptomic analysis of autistic brain and found a euronal module of co-expressed genes which was enriched ith genetically associated variants; an immune-glial module hich showed no such enrichment for autism GWAS signals as interpreted as secondary [127], but this seems to involve…”
Ciernia, A. V., Kramár, E. A., Matheos, D. P., Havekes, R., Hemstedt, T. J., Magnan, C. N., Sakata, K., Tran, A. V., Azzawi, S., López, A. J., et al. (2017) · Learning & Memory · doi:10.1101/lm.044602.116 · Cited by 29
“Furthermore, network analysis has implicated BAF53b in a gene coexpression module associated with decreased expression in ASD cortex samples (Voineagu et al. 2011).”
Levine, A. J., Horvath, S., Miller, E. N., Singer, E. J., Shapshak, P., Baldwin, G. C., Martínez-Maza, O., Witt, M. D., & Langfelder, P. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.09.016 · Cited by 24
“Module membership measures allow one to annotate all genes on the array and to screen for highly connected intramodular hub genes, which may have particular relevance to disease (Ghazalpour et al., 2006; Horvath et al., 2006; Voineagu et al., 2011).”
Self-citationA Consensus Network of Gene Regulatory Factors in the Human Frontal Lobe
Berto, S., Perdomo-Sabogal, Á., Wiegreffe, D., Qin, J., & Nowick, K. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00031 · Cited by 26
“ASD modules (asdM12 and asdM16) were obtained from an independent genome-wide expression study that compared ASD with healthy post-mortem brain tissues (Voineagu et al., 2011).”
BackgroundMethodInfluentialIdentifying Essential Cell Types and Circuits in Autism Spectrum Disorders
Maloney, S. E., Rieger, M. A., & Dougherty, J. D. (2013) · International Review of Neurobiology · doi:10.1016/b978-0-12-418700-9.00003-4 · Cited by 25
“, 2013), though few cerebellar alterations were detected at the transcriptional level (Voineagu et al., 2011).”
BackgroundBrain transcriptome atlases: a computational perspective
Mahfouz, A. E., Huisman, S. M. H., Lelieveldt, B. P. F., & Reinders, M. J. T. (2016) · Brain Structure and Function · doi:10.1007/s00429-016-1338-2 · Cited by 31
“…to analyze expression variation across the brain (Lonsdale 2013), expression developmental dynamics (Oldham et al. 2008; Colantuoni et al. 2011; Kang et al. 2011), and differential expression in the autistic brain (Voineagu et al. 2011), albeit in a limited number of coarse brain regions.”
BackgroundZhang, S., Liu, W., Liu, X., et al. (2017) · Medicine · doi:10.1097/md.0000000000008375 · Cited by 25
“Weighted Gene Co-expression Network Analysis (WGCNA) is a useful approach that has been widely used for gene expressions to identify key disease-related modules.([15]) For instance, using WGCNA, Saris et al([16]) select two large co-expressed modules that related to amyotrophic lateral sclerosis.”
MethodTarget Genes of Autism Risk Loci in Brain Frontal Cortex
Sun, Y., Yao, X., March, M., Meng, X., Li, J., Wei, Z., Abou‐Sleiman, P. M., Hakonarson, H. H., Xia, Q., & Li, J. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00707 · Cited by 28
Autism: considerations for transitions of care into adulthood
Enner, S., Ahmad, S. F., Morse, A. M., & Kothare, S. V. (2020) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000882 · Cited by 28
Reilly, J., Gallagher, L., Leader, G., & Shen, S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242773 · Cited by 31
“Differentially Expressed genes can be found in supporting information from respective publications and in Geo2r (GSE42133 for Pramparo, GSE28521 for Voineagu).”
MethodInfluentialJUN and PDGFRA as Crucial Candidate Genes for Childhood Autism Spectrum Disorder
Li, H., Wang, X., Hu, C., Li, H., Xu, Z., Lei, P., Luo, X., & Hao, Y. (2022) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2022.800079 · Cited by 25
Self-citationFunctional neurogenomics in autism spectrum disorders: A decade of progress
Bicks, L. K., & Geschwind, D. H. (2024) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2024.102858 · Cited by 33
Self-citationMale Gender Bias in Autism and Pediatric Autoimmunity
Becker, K. G. (2012) · Autism Research · doi:10.1002/aur.1227 · Cited by 29
“These include shared genetic associations [Becker, 2007], altered immune pathways at the RNA level [Lintas, Sacco, & Persico, 2012; Voineagu et al., 2011], imbalances in cytokine, chemokine, and antibody profiles [Ashwood et al., 2012; Grether, Croen, Anderson, Nelson, & Yolken, 2010], variations…”
BackgroundProtein kinase WNK3 regulates the neuronal splicing factor Fox-1
Lee, A.-Y., Chen, W., Stippec, S., Self, J., Yang, F., Ding, X., Chen, S., Juang, Y.-C. A., & Cobb, M. H. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215406109 · Cited by 26
“Comparative profiling of splicing in autism spectrum disorder (ASD) and normal brain demonstrated differential Fox-1–mediated splicing of target exons yielding proteins involved in synaptic function in autistic brain (8).”
Genetic, Transcriptomic, and Epigenetic Studies of HIV-Associated Neurocognitive Disorder
Levine, A. J., Panos, S. E., & Horvath, S. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000069 · Cited by 24
Self-citationPrilutsky, D., Kho, A. T., Palmer, N., Bhakar, A. L., Smedemark-Margulies, N., Kong, S. W., Margulies, D. M., Bear, M. F., & Kohane, I. S. (2015) · Molecular Autism · doi:10.1186/s13229-015-0061-9 · Cited by 27
“A module enriched for immune genes and glial markers has been observed in autism spectrum disorder (ASD) human post-mortem brain tissue [27, 28], and immunity response-related pathways were perturbed in Fmr1KO and Tsc2+/− murine cerebellum [29].”
BackgroundSpatiotemporal SERT expression in cortical map development
Chen, X., Petit, E., Dobrenis, K., & Sze, J. Y. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.05.010 · Cited by 28
“In line with this idea, work from several groups mapped many autism risk genes co-expressed only in the midfetal modules (Voineagu et al., 2011; Parikshak et al., 2013; Willsey et al., 2013).”
Xie, Z., Eagleson, K. L., Wu, H., & Levitt, P. R. (2016) · eNeuro · doi:10.1523/eneuro.0074-16.2016 · Cited by 28
“This suggests that the biological impact of reducing MET expression, which occurs in ASD and Rett syndrome (Campbell et al., 2007; Voineagu et al., 2011; Plummer et al., 2013), may differentially disrupt the development of subpopulations of neurons, with specific changes being dependent on the specific repertoire of M…”
BackgroundGudenas, B. L., Srivastava, A. K., & Wang, L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178532 · Cited by 30
Bioinformatics and genomic databases
Chen, J., & Coppola, G. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63233-3.00007-5 · Cited by 30
Increased Expression of miR‐155p5 in Amygdala of Children With Autism Spectrum Disorder
Almehmadi, K., Tsilioni, I., & Theoharides, T. C. (2019) · Autism Research · doi:10.1002/aur.2205 · Cited by 32
“…analyses done on 19 patients with ASD and 17 controls in three brain regions previously implicated in ASD (prefrontal cortex, temporal gyrus, and cerebellum vermis), there were significant changes in 444 genes in cerebral cortex and only two genes in the cerebellum [Voineagu et al., 2011].”
BackgroundMethodInfluentialTamming, R. J., Dumeaux, V., Jiang, Y. Y., Shafiq, S., Langlois, L., Ellegood, J., Qiu, L. R., Lerch, J. P., & Bérubé, N. G. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107838 · Cited by 27
“Developmental neurological diseases such as autism spectrum disorders tend to preferentially affect males, possibly due to combinatorial contributions of hormonal and genetic factors in a phenomenon known as the female protective effect (Fombonne, 2009; Jacquemont et al., 2014; Voineagu et al., 2011), and this has rep…”
BackgroundmultiWGCNA: an R package for deep mining gene co-expression networks in multi-trait expression data
Tommasini, D., & Fogel, B. L. (2023) · BMC Bioinformatics · doi:10.1186/s12859-023-05233-z · Cited by 31
“However, other valid designs are possible, such as: (1) subsetting by disease status [4], which enables study of the secondary trait across wildtype and disease samples separately, or (2) subsetting by the secondary trait itself, which enables study of disease across this other trait, which is…”
BackgroundMethod
Metadata
- Authors
- Voineagu, I., Wang, X., Johnston, P., Lowe, J. K., Tian, Y., Horvath, S., Mill, J., Cantor, R. M., Blencowe, B. J., & Geschwind, D. H.
- Affiliations
- University of California, Los Angeles (US)
- University of Toronto (CA)
- King's College London (GB)
- Corresponding author
- Geschwind, Daniel H.
- ORCID
- Venue
- Nature
- Published
- 2011-05-25
- Volume
- 474
- Issue
- 7351
- Pages
- 380-384
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3607626
- OpenAlex
- W1995647101
- Cited by
- 1,874
- References
- 38
- Citations by year
- 2026: 91 · 2025: 93 · 2024: 95 · 2023: 111 · 2022: 112 · 2021: 141 · 2020: 131 · 2019: 142 · 2018: 132 · 2017: 127 · 2016: 143 · 2015: 136 · 2014: 137 · 2013: 124 · 2012: 120
- FWCI
- 67.49
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Autism Speaks
- Genome Canada
- Ontario Genomics Institute
- National Institutes of Health (5r01mh094714-04)
- Canadian Institutes of Health Research
- Medical Research Council
- National Institute of Mental Health (R01-MH094714, R01MH081754, R37MH060233)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Child Nutrition and Feeding Issues
- Keywords
- autism spectrum disorder, transcriptome, gene co-expression network, splicing dysregulation, A2BP1, alternative exons, autism susceptibility genes, neuronal dysfunction, genetic heterogeneity
- MeSH terms
- RNA Splicing Factors, Autistic Disorder, Brain, Exons, Frontal Lobe, Gene Expression Regulation, Humans, Temporal Lobe, Transcription, Genetic, Case-Control Studies, RNA-Binding Proteins, Alternative Splicing, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.